CIK 0000875320 · Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 043039129
- Phone
- 6173416393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,307,135
- in 1 filing, $6.3M under 10b5-1 plans
Net −$6,307,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-15 | Bunnage Mark E. EVP, Chief Scientific Officer | Sale 10b5-1 | −33 | $453.45 | $15K | 7,284 |
| 2026-05-15 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −1,354 | $453.45 | $614K | 24,734 |
| 2026-05-12 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −6,988 | $450.00 | $3.1M | 26,088 |
| 2026-05-04 | Bhatia Sangeeta N. Director | Sale 10b5-1 | −318 | $423.73 | $135K | 4,924 |
| 2026-05-01 | Upadhyay Suketu Director | Returned to the company | −796 | 1,558 | ||
| 2026-05-01 | Upadhyay Suketu Director | Grant or award · Stock Option (Right to Buy) | +2,866 | 2,866 | ||
| 2026-05-01 | Upadhyay Suketu Director | Grant or award · Deferred Stock Units | +796 | 3,595.16 | ||
| 2026-05-01 | Thornberry Nancy Director | Grant or award | +472 | 2,507 | ||
| 2026-05-01 | Thornberry Nancy Director | Returned to the company | −398 | 2,109 | ||
| 2026-05-01 | Thornberry Nancy Director | Grant or award · Stock Option (Right to Buy) | +1,433 | 1,433 | ||
| 2026-05-01 | Thornberry Nancy Director | Grant or award · Deferred Stock Units | +398 | 398 | ||
| 2026-05-01 | Schneider Jennifer Director | Grant or award | +472 | 2,190 | ||
| 2026-05-01 | Schneider Jennifer Director | Returned to the company | −796 | 1,394 | ||
| 2026-05-01 | Schneider Jennifer Director | Grant or award · Stock Option (Right to Buy) | +1,433 | 1,433 | ||
| 2026-05-01 | Schneider Jennifer Director | Grant or award · Deferred Stock Units | +796 | 796 | ||
| 2026-05-01 | SACHS BRUCE I Director | Grant or award · Stock Option (Right to Buy) | +2,866 | 2,866 | ||
| 2026-05-01 | MCKENZIE DIANA Director | Grant or award | +943 | 3,174 | ||
| 2026-05-01 | MCKENZIE DIANA Director | Returned to the company | −796 | 2,378 | ||
| 2026-05-01 | MCKENZIE DIANA Director | Grant or award · Deferred Stock Units | +796 | 7,787.48 | ||
| 2026-05-01 | Liu Joy EVP and Chief Legal Officer | Sale 10b5-1 | −1,104 | $425.02 | $469K | 20,729 |
Page 2 of 10 · 182 trades